Skip to content
by Legal Desire
13 September 2021

Latham & Watkins Advises Itamar Medical in Acquisition by ZOLL Medical

Advising firms

Deal team

19 lawyers named
LawyerFirmSeniorityPracticeOffice
Hans Brigham Lead Latham & Watkins LLP Partner corporate Boston
Max Schleusener Lead Latham & Watkins LLP Partner corporate Chicago
Ariel Cho Latham & Watkins LLP Associate corporate Not stated
Nathan Ajiashvili Latham & Watkins LLP Partner capital markets New York
Joshua Kiernan Latham & Watkins LLP Partner capital markets London
Michael Rosenberg Latham & Watkins LLP Counsel capital markets New York
Elizabeth Richards Latham & Watkins LLP Partner FDA regulatory Washington, D.C.
Betty Pang Latham & Watkins LLP Counsel FDA regulatory Bay Area
Judith Hasko Latham & Watkins LLP Partner intellectual property Bay Area
Jiqiang Lin Latham & Watkins LLP Associate intellectual property Not stated
Elena Romanova Latham & Watkins LLP Partner tax New York
Shruti Hazra Latham & Watkins LLP Associate tax Not stated
Matthew Conway Latham & Watkins LLP Partner benefits and compensation Washington, D.C.
Ashlie Lawton Latham & Watkins LLP Associate benefits and compensation Not stated
Héctor Armengod Latham & Watkins LLP Partner antitrust Brussels
Ian Conner Latham & Watkins LLP Partner antitrust Washington, D.C.
Patrick English Latham & Watkins LLP Counsel antitrust Washington, D.C.
Damara Chambers Latham & Watkins LLP Partner CFIUS Washington, D.C.
Heather Deixler Latham & Watkins LLP Counsel data privacy and security Bay Area

Stated terms

Stated value
USD 538m (approximately US$538 million)
What the figure measures
Total transaction value
Client
Itamar MedicalSell-side
Counterparties
ZOLL Medical Corporation (Buy-side)